Cargando…

Successful Drug Desensitization to Ustekinumab in a Patient with Crohn's Disease

Ustekinumab is a monoclonal antibody used as treatment for various inflammatory conditions. We present a pediatric patient with Crohn's disease who did not tolerate infliximab and was then changed to ustekinumab. He developed anaphylaxis to the medication after the second dose. A drug desensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Barrie, Tomer, Gitit, Gavrilova, Tatyana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458924/
https://www.ncbi.nlm.nih.gov/pubmed/34720823
http://dx.doi.org/10.1159/000516318

Ejemplares similares